Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma mesotherapy improved symptoms in patients with corticosteroid-induced rosacea-like dermatitis.

Minoxidil solution applied twice daily improved hair growth in patients with Woolly Hair/Hypotrichosis due to LIPH gene issues, with mild side effects.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

Crescina® lotion helps reduce hair loss and increase hair growth in males with androgenetic alopecia.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Researchers identified genes in scalp hair follicles that may affect hair traits and hair loss.

Using bacitracin zinc and selenium sulfide one after the other can temporarily turn white hair yellow.

Epigenetic differences affect hair loss in identical Japanese male twins.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Narrowband-UVB phototherapy successfully treated a rare case of Graham Little-Piccardi-Lassueur syndrome.

Daily use of antifungal shampoo can hide symptoms and make it hard to diagnose fungal scalp infections.

675 nm laser therapy effectively improves hair growth and density in AGA patients.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Intramuscular injections improved hair density more than intradermal injections for treating hair loss.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

People with alopecia areata may have a higher risk of blood clots.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.